|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.912 SEK | -14.77% |
|
-0.87% | -31.17% |
Glycorex Transplantation AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 7.66 million compared to SEK 9.64 million a year ago. Revenue was SEK 9.32 million compared to SEK 10.36 million a year ago.
Net loss was SEK 16.62 million compared to SEK 1.94 million a year ago. Basic loss per share from continuing operations was SEK 0.23 compared to SEK 0.03 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -31.17% | 6.14M | |
| +11.84% | 27.79B | |
| -32.98% | 2.98B | |
| -15.97% | 2.52B | |
| +11.90% | 2.34B | |
| -1.11% | 1.91B | |
| -13.37% | 1.83B | |
| -7.78% | 1.39B | |
| -0.38% | 1.27B | |
| +13.51% | 1.12B |
GLYCOREX TRANSPLANTATION AB 
